PMID: 22572547May 11, 2012Paper

Inhibition of GHRH aggravated acetaminophen-induced acute mice liver injury through GH/IGF-I axis

Endocrine Journal
Tao WangQinggui Zhang

Abstract

The aim of the current study is to investigate the effects of growth hormone releasing hormone (GHRH) antagonist on acetaminophen (APAP)-induced acute liver injury in mice. Healthy C57/B6L mice were orally treated with 200 mg/kg APAP with or without a 30-min pre-treatment with 300 µg/kg GHRH antagonist MZ-5-156. After 12 hours, serum, plasma, and liver samples from each mouse were collected for analyses. Our results showed that twelve-hour treatment with APAP caused obvious liver injury, elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, increased oxidative stress, reduced expressions of antioxidant enzymes, accumulated expression of pro-inflammatory cytokines, and increased circulating levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I). Pre-treatment with MZ-5-156 aggravated liver injury, further increased serum ALT and AST levels, exacerbated oxidative stress and inflammation induced by APAP. Treatment of MZ-5-156 also blocked the phosphorylation form and total form of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5). Treatment of GHRH super-agonist JI-38 immediately after MZ-5-156 treatment partly reversed the liver injury caused ...Continue Reading

References

Dec 1, 1992·Toxicology Letters·H Sies, H de Groot
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D C DahlinS D Nelson
Dec 16, 1993·The New England Journal of Medicine·W M Lee
Oct 1, 1996·Physiological Reviews·L S Argetsinger, C Carter-Su
Oct 17, 1998·Toxicology and Applied Pharmacology·H ZaherF J Gonzalez
Mar 24, 1999·Archives of Surgery·M T ChrysopouloD N Herndon
Nov 5, 1999·Trends in Endocrinology and Metabolism : TEM·A V Schally, J L Varga
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K SzepeshaziG Halmos
Jun 29, 2002·Molecular and Cellular Endocrinology·Ana C P ThironeMario J A Saad
Jan 18, 2003·Receptors & Channels·Bruce D Gaylinn
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Laura P JamesJack A Hinson
Aug 12, 2004·Free Radical Biology & Medicine·Martin D BrandNadeene Parker
Nov 16, 2005·Nature Medicine·Anna A SablinaPeter M Chumakov
Mar 15, 2006·Combinatorial Chemistry & High Throughput Screening·Andrew V Schally, Jozsef L Varga
Jul 31, 2007·The Journal of Thoracic and Cardiovascular Surgery·Yong An, Ying-Bin Xiao
Aug 29, 2007·Clinics in Liver Disease·Anne M Larson
Dec 19, 2009·Handbook of Experimental Pharmacology·Jack A HinsonLaura P James
Oct 22, 2010·Cell Cycle·Nektarios Barabutis, Andrew V Schally

❮ Previous
Next ❯

Related Concepts

Related Feeds